Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies
2025 · 4th Quarter (Oct 1 - Dec 31)
BRIDGEBIO PHARMA, INC.
Filed by BRIDGEBIO PHARMA, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Amendment
- Posted
- Jul 17, 2026
- Income
- Not reported
- Expenses
- $280,000.00
- Registrant
- BRIDGEBIO PHARMA, INC.
- Client
- BRIDGEBIO PHARMA, INC.
- Filing UUID
- f4f6506f-4aee-479f-8ca9-56b322aca586
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.